user warning: Got error 28 from storage engine query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 438907 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.

Antares Pharma Ranks the Highest in Terms of Revenue Per Employee in the Health Care Supplies Industry (AIS, VIVO, CERS)

Published on Fri, 02/08/2013 - 11:18
By Peter Chu

Below are the three companies in the Health Care Supplies industry with the highest Revenue Per Employee (RPE). Analysts use RPE as a measure to compare the productivity of companies in the same industry.

Antares Pharma (AMEX:AIS) is highest with an RPE of $1.1 million. Antares Pharma, Inc. develops pharmaceutical delivery systems, including needle-free and mini-needle injector systems and transdermal gel technologies. The Company distributes its needle-free injector systems in various countries. Antares also conducts research and development with transdermal gel products and has several products in clinical evaluation with partners.

Potential upside of 61.6% exists for Antares Pharma, based on a current level of $3.30 and analysts' average consensus price target of $5.33. The stock should find initial support at its 50-day moving average (MA) of $3.04 and further support at its 200-day MA of $2.60.

Meridian Bioscience (NASDAQ:VIVO) is next with an RPE of $629,000.

Finishing up the top three is Cerus (NASDAQ:CERS), with an RPE of $464,000.

By Peter Chu
pchu@fnno.com